At a glance
ClinicalIndex Comparison RecordN/ACompleted· 245 enrolled
Drug / intervention
Laparoscopic sleeve gastrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life After Laparoscopic Sleeve Gastrectomy
In Brief
An observational study evaluating Laparoscopic sleeve gastrectomy for Sarcopenic Obesity and Body Composition. Completed, enrolled 245 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the impact of sarcopenic obesity (SO) on weight loss outcomes and improvement of quality of life after laparoscopic sleeve gastrectomy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcopenic Obesity, Body Composition
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
Primary CompletionJul 2022
Study CompletionDec 2022
First PostedApr 2023
TodayJul 2026
First PostedApr 24, 2023
Enrollment StartJan 1, 2015
Primary CompletionJul 1, 2022
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 3.2 years ago
Interventions
Laparoscopic sleeve gastrectomyprocedure
Laparoscopic sleeve gastrectomy was performed in all patients with or without SO.